JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M202430200 on April 15, 2002

J. Biol. Chem., Vol. 277, Issue 25, 22534-22540, June 21, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/25/22534    most recent
M202430200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gascón, I.
Right arrow Articles by Salas, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gascón, I.
Right arrow Articles by Salas, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Importance of the N-terminal Region of the Phage GA-1 Single-stranded DNA-binding Protein for Its Self-interaction Ability and Functionality*

Irene GascónDagger , José L. Carrascosa§, Laurentino VillarDagger , José M. LázaroDagger , and Margarita SalasDagger

From the Dagger  Centro de Biología Molecular "Severo Ochoa" (Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid) and the § Centro Nacional de Biotecnología (Consejo Superior de Investigaciones Científicas), Universidad Autónoma, Cantoblanco, 28049 Madrid, Spain

Received for publication, March 13, 2002, and in revised form, April 10, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The single-stranded DNA-binding protein (SSB) of phage GA-1 displays higher efficiency than the SSBs of the related phages phi 29 and Nf. In this work, the self-interaction ability of GA-1 SSB has been analyzed by visualization of the purified protein by electron microscopy, glycerol gradient sedimentation, and in vivo cross-linking of bacterial cultures infected with phage GA-1. GA-1 SSB contains an insert at its N-terminal region that is not present in the SSBs of phi 29 and Nf. Three deletion mutant proteins have been characterized, Delta N19, Delta N26, and Delta N33, which lack the 19, 26 or 33 amino acids, respectively, that follow the initial methionine of GA-1 SSB. Mutant protein Delta N19 retains the structural and functional behavior of GA-1 SSB, whereas mutant proteins Delta N26 and Delta N33 no longer stimulate viral DNA replication or display helix-destabilizing activity. Analysis of the mutant proteins by ultracentrifugation in glycerol gradients and electron microscopy indicates that deletion of 26 or 33 but not of 19 amino acids of the N-terminal region of GA-1 SSB results in the loss of the oligomerization ability of this protein. Our data support the importance of the N-terminal region of GA-1 SSB for the differential self-interaction ability and functional behavior of this protein.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Single-stranded DNA-binding proteins (SSBs)1 contribute to DNA metabolism, playing essential roles in different processes such as DNA replication, repair, and recombination (1-3). SSBs bind single-stranded DNA (ssDNA) in a selective, cooperative, and non-sequence-specific way, protecting it from nuclease attack and preventing the formation of secondary structures on it. SSBs are ubiquitous. They have been isolated from bacteria and their phages, eukarya and their viruses, and archaea (1-6).

Different oligomerization states have been reported for SSBs. Thus, monomeric (T4gp32 from bacteriophage T4 or AdDBP from adenovirus (5)), dimeric (SSBs from filamentous phages M13 (1) and Pf3 (7)), homotetrameric (EcoSSB from Escherichia coli (2, 8) or human mitochondrial SSB (9)), and heterotrimeric (hRPA, human RPA (3)) SSBs have been described. Important differences have been also reported mainly concerning the amino acid sequence and ssDNA binding properties of the proteins of this family.

The function of the SSB is particularly important in the case of organisms that replicate their genetic material via a protein-priming mechanism followed by strand displacement, as large amounts of ssDNA are generated in the process (10-12). This is the case of adenovirus and of the phi 29 family of Bacillus phages. The genome of the latter consists of a linear dsDNA molecule of about 20 kb that contains a phage-encoded terminal protein (TP) covalently linked to each 5' end. Replication of the viral genome starts at either DNA end non-simultaneously by a protein-priming mechanism. After a sliding-back step (13), the viral DNA polymerase elongates the initiation product proceeding by strand displacement toward the other DNA end. The displaced strand is cooperatively bound by the viral SSB. When two growing chains, running from opposite ends, collide and separate, two DNA molecules are generated where strand displacement is no longer required (10-12) and where the SSB must be eliminated from the ssDNA by the advancing DNA polymerase.

The phi 29 family of phages has been classified into three evolutionary branches according to the comparison of nucleotide and amino acid sequences of selected DNA regions and proteins (14, 15). One branch is composed of phages phi 29, PZA, phi 15, and BS32; the second branch consists of phages Nf, B103, and M2Y; and the third branch has phage GA-1 as its sole member (15).

Initial studies carried out with the SSB of phi 29 indicated that it has ability to protect ssDNA against nuclease degradation (16) and to bind the ssDNA generated during viral DNA replication in vitro, as analyzed by electron microscopy (17). Furthermore, it was determined that phi 29 SSB has helix-destabilizing ability (18), and the parameters of the complex it forms with ssDNA were defined (19).

Recent comparison of phi 29 SSB with the SSBs of phages Nf and GA-1, representative examples, respectively, of the second and third branches in which the phi 29 family of phages is divided, indicate that, despite some global similarities, GA-1 SSB displays significant functional and structural differences with respect to the other two SSBs. Thus, it binds ssDNA with higher affinity and displays helix-destabilizing ability with lower protein concentrations than the other two SSBs (20, 21). The complex formed by GA-1 SSB with ssDNA is clearly different from the phi 29-like nucleoprotein complex, as determined by electron microscopy in the presence of DNA (19, 20). Thus, GA-1 SSB produces an average 6-fold reduction in the length of the ssDNA in contrast to the 2-fold reduction factor obtained upon binding of phi 29 SSB to ssDNA. Besides, the nucleoprotein complex formed by GA-1 SSB shows a compact beaded appearance (20), very different from the simple array of protein monomers of phi 29 SSB·ssDNA fibers (19). Further approaches oriented to the structural comparison of the three SSBs indicate that phi 29 and Nf SSBs behave as monomers in solution in glycerol gradients, whereas GA-1 SSB self-interacts sedimenting at a position corresponding to an average hexameric complex. This differential self-interaction ability correlates with a higher efficiency of GA-1 SSB in functional assays.

Amino acid sequence comparison of the three SSBs highlights the high degree of homology between phi 29 and Nf SSBs, as well as the higher divergence of GA-1 SSB. The latter contains an insert at its N-terminal region that is lacking in the other two SSBs (21).

In the present report, further approaches to the characterization of GA-1 SSB have been carried out. Thus, the self-interaction ability of GA-1 SSB has been analyzed by visualization of the purified protein by electron microscopy in the absence of DNA, by glycerol gradient sedimentation, and by in vivo cross-linking of bacterial cultures infected with phage GA-1. Furthermore, the effect of the partial or complete deletion of the N-terminal insert of GA-1 SSB on the self-interaction ability of the protein as well as on its functional activity has been also examined. We show that a mutant protein lacking the 19 N-terminal amino acids retains the structural and functional behavior of GA-1 SSB, whereas mutants lacking 26 or 33 amino acids from the N-terminal end are greatly affected. The influence of the N-terminal region of GA-1 SSB on the self-interaction ability of the protein and the requirement of this ability for an efficient functional behavior are also discussed.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Nucleotides and DNA-- Phage phi 29 TP-DNA was isolated as described (22). Oligonucleotides were obtained from Isogen, and plasmid pALTER-Ex2 from Promega. [alpha -32P]dATP (3000 Ci/mmol) and [gamma -32P]ATP (3000 Ci/mmol) were obtained from Amersham Biosciences. Unlabeled nucleotides and M13mp18 ssDNA were from Amersham Biosciences. DNA sequencing was carried out in the Servicio Interdepartamental de Investigación of the Universidad Autónoma de Madrid.

Proteins-- Vent DNA polymerase, T4 DNA ligase, and restriction enzymes BamHI and EcoRI were purchased from New England Biolabs. The phi 29 DNA polymerase, TP, and DBP were overproduced in E. coli and purified as described (23-25). GA-1 SSB was purified from infected Bacillus sp. G1R cells (26) as previously described (21).

Construction of Plasmids-- Using GA-1 DNA as template and the appropriate oligonucleotide primers, DNA fragments corresponding to the mutant proteins Delta N19, Delta N26, and Delta N33 were amplified by PCR. Vent DNA polymerase, which contains a proofreading function, was used. The primers corresponding to the N-terminal region of each protein contained a recognition site for BamHI, whereas the oligonucleotide corresponding to the C-terminal region, common to all of them, contained a recognition site for EcoRI.

PCR-generated DNA fragments were digested with BamHI and EcoRI, and then cloned into the BamHI and EcoRI sites of plasmid pALTER-Ex2. All the clones generated from the PCR-amplified DNA were sequenced and found to be correct.

Purification of the Mutant Proteins-- E. coli JM109 cells (endA1 recA1 gyrA96 thi hsdR17 (rk-, mk+) relA1 supE44 Delta (lac-proAB) (F' traD36 proAB+ lacIqZDelta M15)) (27) carrying the plasmids of interest were grown at 37 °C in LB broth (28) supplemented with 10 mg/ml tetracycline. At a cell density corresponding to A600 = 0.5, isopropyl-1-thio-beta -D-galactopyranoside (Sigma) was added to a final concentration of 1 mM. Further incubation was at 37 °C for 3 h. Bacteria were harvested by centrifugation and after cell disruption by grinding with alumina (2:1, w/w), resuspended in buffer A (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 7 mM beta -ME, and 5% glycerol) in the presence of 0.4 M NaCl. All purification steps were carried out at 4 °C. The supernatant of a 1500 × g centrifugation step of 5 min was further centrifuged for 20 min at 20,000 × g. Mutant proteins Delta N26 and Delta N33 were recovered in the supernatant of this centrifugation step, whereas Delta N19 was mainly contained in the sediment. DNA was removed from the supernatant corresponding to proteins Delta N26 and Delta N33 by addition of polyethyleneimine to 0.3% after adjusting the absorbance at lambda 260 nm to 120 units/ml and centrifugation for 20 min at 20,000 × g. The supernatant was made 0.1 M NaCl with buffer A, and the proteins were recovered in the supernatant after centrifugation as above. The samples were precipitated with 65% ammonium sulfate, dissolved in buffer A, and, after dialysis against the same buffer, applied to the following columns: in the case of Delta N26, phosphocellulose, heparin-agarose, Mono-Q, and hydroxyapatite; in the case of Delta N33, phosphocellulose, heparin-agarose, DEAE-cellulose, and Mono-Q. Mutant protein Delta N19 was recovered from the sediment with denaturation buffer (25 mM Tris-HCl, pH 7.5, 1 mM EDTA, 25% glycerol (v/v), 10 mM DTT, and M guanidinium chloride). After centrifugation for 20 min at 20,000 × g, the supernatant was dialyzed against renaturation buffer (25 mM Tris-HCl, pH 7.5, 1 mM EDTA, 25% glycerol (v/v), 10 mM DTT, and 0.1 M NaCl) and centrifuged under the same conditions. The supernatant containing the native protein was applied to the following columns: phosphocellulose, heparin-agarose, and Mono-Q. In all three cases, protein samples eluted from the last column were precipitated with ammonium sulfate up to 65%, dissolved in buffer A, and dialyzed against the same buffer containing 50% glycerol (v/v). In all purification steps, proteins were followed by SDS-PAGE (10-20% acrylamide gradients). Protein concentration was determined both by the Lowry method and by comparison with a known amount of BSA in polyacrylamide gel electrophoresis.

In Vivo Cross-linking of GA-1 SSB-- Both noninfected and GA-1-infected Bacillus sp. G1R cell cultures were harvested after 15 min of infection at 37 °C. Aliquots of 1.5 ml were centrifuged at 4 °C, and the corresponding pellets were incubated with increasing amounts of the cross-linking agent BS3 (Pierce) in a final volume of 200 µl. After 30 min at room temperature, 40 µl of 1 M Tris-HCl, pH 7.5, were added to each reaction to quench it. After centrifugation, pellets were resuspended in 300 µl of loading buffer, samples sonicated, and aliquots of 10 µl loaded on to 10-20% SDS-PAGE. Proteins were electrophoretically transferred for 70 min at 100 mA and 4 °C to PVDF membranes using a transfer buffer containing 25 mM Tris, 192 mM glycine, and 20% (v/v) methanol. Membranes were incubated with 1/1000 diluted rabbit antibodies against GA-1 SSB. Antigen-antibody complexes were detected with anti-rabbit horseradish peroxidase-linked antibody and ECL Western blotting detection reagent (both from Amersham Biosciences). Prestained molecular weight markers were loaded in the gel as molecular weight controls.

TP-DNA Amplification Assay-- The incubation mixture contained, in 25 µl, 50 mM Tris-HCl, pH 7.5, 1 mM DTT, 4% glycerol, 0.1 mg/ml BSA, 20 mM ammonium sulfate, 10 mM MgCl2, 80 µM each dCTP, dGTP, dTTP, and [alpha -32P]dATP (2 µCi), 3.4 ng of phi 29 TP-DNA, 7 ng of DNA polymerase, 25 ng of TP, and 10 µg of DBP, all from phi 29. The indicated amounts of GA-1 SSB, the mutant proteins or the corresponding buffer were added. After incubation for 1 h at 30 °C, reactions were stopped by adding EDTA up to 10 mM and SDS up to 0.1% (w/v), and the samples were filtered through Sephadex G-50 spin columns in the presence of 0.1% SDS. The excluded volume was subjected to alkaline agarose gel electrophoresis as described (29), followed by autoradiography and ethidium bromide staining.

Helix-destabilizing Assay-- The incubation mixture contained, in 12.5 µl, 62.5 ng of primed M13mp18 ssDNA, 50 mM Tris-HCl, pH 7.5, 4% glycerol, 0.1 mg/ml BSA, and the indicated amounts of GA-1 SSB, the mutant proteins or the corresponding buffer. After 30 min at 37 °C, reactions were stopped with 1.25 µl of 0.25% (w/v) bromphenol blue, 0.25% (w/v) xylene cyanol, 30% glycerol, and 0.5% SDS. Samples were subjected to electrophoresis at 4 °C in an 8% polyacrylamide gel containing 0.1% SDS. The gel was dried and autoradiographed.

Gel Mobility-shift Assays-- The incubation mixture contained, in a final volume of 20 µl, a heat-denatured alpha -32P-labeled phi 29 DNA HindIIIL fragment and the indicated amounts of phi 29, Nf, or GA-1 SSB in 50 mM Tris-HCl, pH 7.5, and 4% glycerol. After incubation for 5 min at 4 °C, the samples were subjected to electrophoresis in 4% polyacrylamide gels containing 12 mM Tris acetate, pH 7.5, and 1 mM EDTA, and run at 4 °C in the same buffer at 8 V/cm essentially as described (30). After drying, the gels were autoradiographed and the SSB·ssDNA complexes detected as mobility of the labeled DNA.

Glycerol Gradient Assays-- Glycerol gradients (15-30%), containing 50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 7 mM beta -ME, and 25 mM NaCl (loading buffer), were formed in 5-ml Beckman polyallomer centrifuge tubes (13 × 51 mm). 100 µl of a 50 µM preparation of GA-1 SSB or each mutant protein in loading buffer, and the corresponding amounts of molecular weight markers, were loaded onto different gradients. After centrifugation at 62,000 × g and 4 °C in a Beckman SW.65 rotor for 24 h, the fraction number at which the maximal amount of each protein appears was determined by interpolating in the graphic elaborated with the molecular weight markers, as described (20).

Electron Microscopy-- GA-1 SSB or the mutant proteins (10 µl of a 55 µM solution) were applied to carbon-coated copper grids for 2 min. Grids were then washed with a few drops of water and stained for 30 s with 2% uranyl acetate. Electron micrographs were taken in a Jeol 1010 electron microscope at 80 kV.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Analysis of the Ability of GA-1 SSB to Self-interact by Electron Microscopy and in Vivo Cross-linking-- The ability of GA-1 SSB to self-interact was analyzed both by visualization of the purified protein by electron microscopy and by in vivo cross-linking of bacterial cultures infected with phage GA-1. After negative staining, GA-1 SSB was visualized in the absence of DNA and chemical cross-linking reagents by electron microscopy as described under "Experimental Procedures." Under these conditions purified GA-1 SSB oligomerized in vitro, as can be observed in Fig. 1A, which shows a representative example of the most abundant structures formed by wt GA-1 SSB. They consist of protein filaments of different lengths and a diameter of ~10 nm. Along with these filaments, protein structures where regions of different compacting levels coexist were detected, like the one displayed in Fig. 1B.


View larger version (131K):
[in this window]
[in a new window]
 
Fig. 1.   Visualization of GA-1 SSB by electron microscopy. A, field showing filaments of different lengths and ~10-nm diameter. B, coexistence of different compacting levels within the same structure.

The ability of GA-1 SSB to self-interact was also analyzed in vivo by treatment of GA-1-infected Bacillus sp. G1R cell cultures with the cross-linking agent BS3, followed by Western blot analysis with antibodies raised against GA-1 SSB (for details, see "Experimental Procedures"). Fig. 2 shows both noninfected (-I) and GA-1-infected (+I) cell cultures after treatment with increasing amounts of the cross-linking agent. Positions corresponding to the mono-, di-, tri-, and tetrameric forms of the protein are indicated. Oligomers of higher molecular mass were also detected. Additional bands appear that could correspond to interaction of GA-1 SSB with other proteins.


View larger version (94K):
[in this window]
[in a new window]
 
Fig. 2.   Ability of GA-1 SSB to self-interact in vivo. Noninfected (-I) and GA-1-infected (+I) Bacillus sp. G1R cultures were harvested, treated with the indicated amounts of BS3, and subjected to 10-20% SDS-PAGE. Western blot analysis of the gel was then carried out. Positions corresponding to the mono-, di-, tri-, and tetrameric forms of the protein are indicated at the right. Increasing amounts of GA-1 SSB were used as control.

Deletion of the N-terminal Region of GA-1 SSB Affects Its Stimulatory Effect on Viral DNA Replication-- Previous studies indicate that GA-1 SSB displays differential structural and functional behavior to those of the SSBs of the related phages phi 29 and Nf (20, 21). GA-1 SSB contains an insert on its N-terminal region, rich in polar and aromatic amino acids, which is not present in the SSBs of the related phages phi 29 and Nf (see Fig. 3). To analyze the effect of the partial or complete deletion of this insert on the global activity of GA-1 SSB, the three mutant proteins Delta N19, Delta N26, and Delta N33 indicated in Fig. 3 were expressed from the corresponding plasmids in E. coli JM109 cells and purified as previously described. Delta N19, Delta N26, and Delta N33 lack the 19, 26, or 33 amino acids, respectively, that follow the initial methionine residue of GA-1 SSB. All three proteins were purified to near homogeneity. The ability of the mutant proteins to stimulate viral DNA replication was analyzed in a TP-DNA amplification assay using the phage phi 29 DNA amplification system (31). The increasing amounts indicated in Fig. 4, either of GA-1 SSB or of the mutant proteins Delta N19, Delta N26, and Delta N33, were incubated with phi 29 TP-DNA, DNA polymerase, TP, and DBP, under the conditions described under "Experimental Procedures." As can be seen in Fig. 4, the stimulatory effect of Delta N19 was similar to that of wt GA-1 SSB. Thus, dNTP incorporation in the presence of 3.5 µM Delta N19 was 85% of that obtained with the same concentration of the wt protein. However, the activity of Delta N26 and Delta N33 was significantly affected (compare the stimulatory effects with a concentration of 14 µM for each protein in Fig. 4). Thus, the activity of the mutant proteins Delta N26 and Delta N33 was 9 and 5%, respectively, of that of wt GA-1 SSB. Not even with a concentration of 55 µM for the mutant proteins Delta N26 and Delta N33 did dNTP incorporation reach the levels obtained with 3.5 µM wt protein. Furthermore, addition of concentrations as high as 250 µM for the mutant proteins Delta N26 and Delta N33 did not significantly improve the levels of dNTP incorporation (data not shown). The lack of global functional efficiency of mutant proteins Delta N26 and Delta N33 is discussed below, and a comparison with the SSBs of phi 29 and Nf is also established.


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 3.   Sequence alignment of phi 29, Nf, and GA-1 SSBs. Identical residues in the three SSBs are white on a black background. Similar residues of the phi 29 and/or Nf SSBs with respect to the GA-1 SSB, the least related of them, are black on a gray background. Similarities between the phi 29 and Nf SSBs are not highlighted. Numbers indicate the amino acid position. The first amino acids that follow the initial methionine residue in the Delta N19, Delta N26, and Delta N33 mutant proteins of GA-1 SSB are indicated with arrows. The polar and aromatic residues within the N-terminal region are also highlighted.


View larger version (66K):
[in this window]
[in a new window]
 
Fig. 4.   Stimulatory effect of GA-1 SSB or the mutant proteins Delta N19, Delta N26, and Delta N33 on viral DNA replication using the phi 29 DNA amplification system. The indicated amounts of each protein were added to the reaction mixture. Electrophoresis mobility of full-length phi 29 TP-DNA is also indicated.

The N-terminal Region of GA-1 SSB Is Essential for Its Helix-destabilizing Activity-- The helix-destabilizing ability of GA-1 SSB mutant proteins Delta N19, Delta N26, and Delta N33 was examined on a substrate consisting of M13 ssDNA to which a 5' radioactively labeled 17-mer oligonucleotide had been hybridized. This substrate was incubated with increasing amounts of GA-1 SSB or the mutant proteins, and the reaction products analyzed by native polyacrylamide gel electrophoresis. As can be seen in Fig. 5, Delta N19 mutant protein displayed the same helix-destabilizing ability as the wt GA-1 SSB, displacing all the 17-mer oligonucleotide from the M13 ssDNA with a 10 µM protein concentration. As also shown in Fig. 5, neither Delta N26 nor Delta N33 mutant proteins were able to displace the oligonucleotide, even at protein concentrations as high as 160 µM.


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 5.   Helix-destabilizing activity of GA-1 SSB and of the mutant proteins Delta N19, Delta N26, and Delta N33. M13 ssDNA to which 5' radioactively labeled 17-mer oligonucleotide was hybridized was incubated with increasing amounts of each protein. Positions of the hybrid substrate and the displaced oligonucleotide are indicated. C is the control of the heat-denatured substrate.

Deletion of the N-terminal Region of GA-1 SSB Does Not Fully Abolish Its Ability to Bind ssDNA-- To determine whether the lack of functional efficiency displayed by the mutant proteins Delta N26 and Delta N33 on TP-DNA amplification and dsDNA unwinding was a consequence of their inability to bind ssDNA, the affinity of these mutant proteins for ssDNA was tested in a gel-mobility shift assay. For this purpose, a radioactively labeled 273-nt-long ssDNA fragment was incubated with increasing amounts of either the mutant proteins or the wt GA-1 SSB. As can be seen in Fig. 6, both Delta N26 and Delta N33 displayed a lower affinity for ssDNA than wt GA-1 SSB. Thus, although GA-1 SSB shifted the band corresponding to free ssDNA with a concentration of 1 µM, a 5-fold higher concentration of Delta N26 was required to produce the same effect. This protein concentration did not suffice in the case of Delta N33 to shift all the DNA present in the assay. Instead, complete binding of all the DNA present in the assay was achieved in the case of this protein with a concentration of 8 µM (data not shown). Mutant protein Delta N19 displayed affinity for ssDNA similar to that of the wt GA-1 SSB (data not shown). These results indicate that, although deletion of the 26 or 33 N-terminal amino acids affects the affinity of GA-1 SSB for ssDNA, it does not fully abolish the ability of the protein to bind ssDNA.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 6.   Gel mobility shift assay of wt GA-1 SSB, Delta N26, and Delta N33 mutant proteins. A radioactively labeled 273-nt-long ssDNA fragment was incubated with the indicated amounts of GA-1 SSB, Delta N26, or Delta N33 at 4 °C and subjected to electrophoresis in a 4% polyacrylamide gel as described under "Experimental Procedures." The band corresponding to the protein-free ssDNA is indicated (D).

Oligomeric State of Delta N19, Delta N26, and Delta N33 Mutant Proteins-- When GA-1 SSB is subjected to ultracentrifugation in a glycerol gradient, it sediments in the average position corresponding to a hexameric complex (20). It must be taken into account, however, that the shape of the aggregate may affect its sedimentation behavior. This approach was also used in the case of the mutant proteins to determine whether the ability of GA-1 SSB to oligomerize was affected by deletion of its N-terminal region. For this purpose, samples of either wt GA-1 SSB (data not shown) or the mutant proteins Delta N19, Delta N26, and Delta N33 (Fig. 7) were subjected to glycerol gradient centrifugation, and the fractions were analyzed by SDS-PAGE. Densitometric analysis of the corresponding gels allowed us to conclude that Delta N19 (17.0 kDa/monomer) sediments in an average position of 106 kDa that would correspond to an hexamer, as wt GA-1 SSB (20). By contrast, the protein peak in the case of Delta N26 mutant protein (16.1 kDa/monomer) is ~51 kDa. This position would correspond to a trimeric complex of Delta N26. Aggregation ability of Delta N33 mutant protein (15.2 kDa) is even more affected, with a sedimentation peak at ~29 kDa that would correspond to a dimeric complex. Thus, deletion of 26 or 33 but not of 19 amino acids of the N-terminal region of GA-1 SSB results in loss of the oligomerization ability of the protein.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 7.   Determination of the oligomerization state of Delta N19 (A), Delta N26 (B), and Delta N33 (C) mutant proteins. 100 µl of each mutant protein (50 µM concentration) was subjected to sedimentation in 15-30% (w/v) glycerol gradients in the presence of molecular weight markers, as described under "Experimental Procedures." After centrifugation, the fractions were analyzed by SDS-PAGE. The fractions at which the maximal amount of each protein appear are indicated in each panel. The markers used are: AD, alcohol dehydrogenase (150 kDa); BSA, bovine serum albumin (66 kDa); CA, carbonic anhydrase (29 kDa); and L, lysozyme (14 kDa). The molecular mass estimation of each mutant protein was carried out as indicated under "Results."

Visualization of the Deletion Mutant Proteins by Electron Microscopy-- Analysis of the deletion mutant proteins by negative-stain electron microscopy was carried out in the absence of DNA as already described for wt GA-1 SSB. The appearance of protein Delta N19 in solution was identical to that of the filaments formed by GA-1 SSB (data not shown). In contrast, in the case of the mutant proteins Delta N26 and Delta N33, the ability to form protein filaments is abolished. Instead, smaller, ring-shaped structures like the ones shown in Fig. 8A for Delta N26, were detected. Delta N33 formed the same kind of structures (data not shown). A closer view of these structures is displayed in Fig. 8B. A correlation between the inability of these mutant proteins to form filaments and their loss of functionality is suggested under "Discussion."


View larger version (119K):
[in this window]
[in a new window]
 
Fig. 8.   A, field showing the ring-shaped structures formed by Delta N26 mutant protein. B, closer view of the structures. The bar represents 100 nm.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

When compared with the SSBs of related phages, the SSB of phage GA-1 displays some noticeable features, one of them being its self-association ability. Thus, on the one hand, even in the absence of ssDNA, GA-1 is able to form filamentous and helicoidal structures that can be visualized by electron microscopy. Under these experimental conditions, neither of the SSBs of the related phages phi 29 and Nf are able to form these high order aggregates.2 On the other hand, when subjected to ultracentrifugation in glycerol gradients, phi 29 and Nf SSBs behave as monomers in solution, whereas GA-1 SSB sediments in the average position of an hexameric complex (20). It must be taken into account that protein-assembly processes are strictly dependent of protein concentration. Thus, the fact that a 10-fold lower protein concentration was used in glycerol gradient centrifugation than in electron microscopy may explain why no material was detected at the bottom of the tube of the GA-1 SSB gradient that would correspond to the filament-forming protein population. However, filament disruption because of the more drastic experimental conditions of the ultracentrifugation with respect to the electron microscopy experiments cannot be ruled out. In vivo cross-linking of Bacillus cultures infected with phage GA-1 confirms the ability of GA-1 SSB to self-interact, although under our experimental conditions monomers and low molecular weight oligomers were seen in addition to high order aggregates that could correspond to the protein filaments. Anyway, whether the filaments formed by GA-1 SSB are the active form of the protein or not, at least they are representative of the differential ability of the protein to self-interact, which is lacking in the SSBs of the related phages phi 29 and Nf.

The importance of the self-interaction ability of GA-1 SSB is further demonstrated by the results obtained with the deletion mutants Delta N19, Delta N26, and Delta N33 of the N-terminal region of the protein. Deletion of the 26 and 33, but not of the 19, amino acids that follow the initial methionine residue of GA-1 SSB results in the abolishment of the helix-destabilizing ability of the wt protein, as well as in a drastic reduction of its functional efficiency in DNA replication assays. These activities are much more affected in GA-1 SSB deletion mutant proteins than in phi 29 and Nf SSBs, proteins that also lack the N-terminal region present in GA-1 SSB. Thus, both phi 29 and Nf SSBs are able to displace the oligonucleotide hybridized to the M13 ssDNA molecule with a protein concentration of 40 µM versus 10 µM GA-1 SSB (21), whereas no destabilization of the oligonucleotide was obtained with a concentration of the mutant proteins Delta N26 and Delta N33 as high as 160 µM. Furthermore, in the phi 29 DNA amplification system, equivalent stimulatory effects of DNA replication to those of GA-1 SSB were obtained with 5-fold higher concentrations of phi 29 SSB (20), whereas dNTP incorporation levels equivalent to those obtained with 3.5 µM GA-1 SSB were not reached with Delta N26 and Delta N33 GA-1 SSB deletion mutants, even with 250 µM protein concentration. These effects are not just a consequence of the inability of the mutant proteins to bind ssDNA, as they conserve this ability, although somewhat affected with respect to that of GA-1 SSB. Besides, as inferred from the data presented in this paper, deletion of the 26 or 33 but not of the 19 amino acids of the N-terminal region of GA-1 SSB results in a loss of the oligomerization ability of this protein, as observed by ultracentrifugation in glycerol gradients. Furthermore, mutant proteins Delta N26 and Delta N33 are no longer able to form filaments, as visualized under the electron microscope. All these experimental evidences indicate that, in contrast with phi 29 and Nf SSBs, GA-1 SSB requires its differential self-interaction ability for an efficient functional behavior, and that the N-terminal region of GA-1 SSB comprised between amino acids 19 and 26 plays an essential role on it. Structural defects in GA-1 SSB that affect the self-interaction ability correlate well with a drastic reduction of its functional efficiency. At the present time mutant phages containing GA-1 SSB proteins Delta N19, Delta N26, and Delta N33 are not available. Therefore, no experiments in vivo have been done to determine whether oligomerization of GA-1 SSB is required for its biological activity.

The fact that, in contrast with Delta N26 and Delta N33, the mutant protein Delta N19 behaves like the wt GA-1 SSB draws our attention to the amino acid residues of this region, the main distinguishable feature of which is the abundance of polar and aromatic residues. Thus, 2 of 7 of the amino acids that are present in Delta N19 but not in Delta N26 are positively charged, 1 has negative charge, and 2 more are aromatic (see Fig. 3). Furthermore, 3 of 7 amino acids present in Delta N26 but not in Delta N33 have positive charge, 1 is negatively charged, and 1 is aromatic. All these data together suggest that the residues of the N-terminal region of GA-1 SSB could be establishing electrostatic interactions important for the differential self-association ability of this protein. An additional piece of evidence that would point in this direction is the fact that, when GA-1 SSB is subjected to ultracentrifugation in glycerol gradient in the presence of 0.2 M NaCl, it behaves like a monomer.2 In addition, no protein filaments are visible by electron microscopy when GA-1 SSB is in the presence of 1 M NaCl.2 This kind of behavior has already been detected in proteins that bind ssDNA and that play important roles in recombination events, such as T4 uvsY or RecA. Thus, T4 uvsY, essential in the formation of the presynaptic filament of phage T4 because of its noncooperative binding to ssDNA and establishment of specific interactions with other proteins of the T4 recombination machinery, forms hexamers capable of reversible association into higher aggregates in a manner dependent on both salt and protein concentration (32). Additionally, RecA, which promotes homologous pairing and exchange of DNA strands ubiquitously in eubacteria, has a monomer-hexamer-higher aggregate self-association state strongly dependent on the kind and concentration of the salt as well as on the protein concentration (33). Nevertheless, RecA is active only as a helical filament of indefinite length polymerized on DNA, and even in the absence of DNA it can self-assemble into a variety of multimeric forms (34). Resolution of the crystal structure of RecA reveals that the N-terminal region of the molecule (residues 1-30) is formed by an alpha -helix followed by a beta -strand, and protrudes from the rest of the molecule stabilizing polymer formation (35). Interestingly, secondary structure predictions of the N-terminal region of GA-1 SSB point to the existence of a similar structure to that of the N-terminal region of RecA. These evidences support the importance of an alpha -beta domain in these proteins for promoting filament formation.

The only examples of SSBs in which the effect of the deletion of a part of the protein resembles that of GA-1 SSB and with similar self-interaction ability to that of GA-1 SSB are the SSBs of herpes simplex virus type I (ICP8) and the SSB of adenovirus (AdDBP). ICP8 is a 128-kDa protein able to form protein filaments in the absence of DNA, although it sediments as a monomer in glycerol gradients (36). Deletion of its 60-amino acid C-terminal region does not affect the intrinsic DNA-binding ability of the protein, but results in a total loss of cooperativity on long ssDNA stretches (37). It has been demonstrated that ICP8 interacts with other components of the replication machinery, like UL9 protein helicase (38-40) or the herpes simplex virus-1 DNA polymerase and helicase-primase (41-45). On the other hand, AdDBP is able to form small aggregates visible under the electron microscope. Resolution of the crystal structure of AdDBP suggested that its C-terminal extension could hook on to an adjacent monomer (46). As a matter of fact, deletion of this C-terminal arm results in a greatly reduced affinity for ssDNA and unwinding activity of the protein (47). As already mentioned, adenovirus replicates its genome via a protein-priming mechanism like the one displayed by the phages of the phi 29 family. Like the SSBs of these phages, AdDBP cooperatively binds to the displaced DNA strand. However, AdDBP has additional roles during adenovirus DNA replication, like the indirect stimulation of the initiation step by increasing the binding of NFI to the replication origin (48, 49), and a direct stimulation by lowering the Km for the first dNTP (50). Taking together these data with the differences displayed by GA-1 SSB with respect to the SSBs of the related phages phi 29 and Nf, it is possible that GA-1 SSB might be implicated in additional roles to those common to the replication systems of the three phages. Future studies concerning phage GA-1 SSB will be oriented to shed some light into possible additional roles of this protein.

    ACKNOWLEDGEMENTS

We are grateful to L. Blanco, A. Bravo, A. Abril, and G. Serrano-Heras for very helpful discussions.

    FOOTNOTES

* This work was supported by Grant 2R01 GM27242-23 from the National Institutes of Health, Grants PB-98-0645 and PB96-818 from Dirección General de Investigación Científica y Técnica, and an institutional grant from Fundación Ramón Areces to the Centro de Biología Molecular "Severo Ochoa."The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 34-91-397-8435; Fax: 34-91-397-8490; E-mail: msalas@cbm.uam.es.

Published, JBC Papers in Press, April 15, 2002, DOI 10.1074/jbc.M202430200

2 I. Gascón, unpublished data.

    ABBREVIATIONS

The abbreviations used are: SSB, ssDNA-binding protein; ssDNA, single-stranded DNA; dsDNA, double-stranded DNA; TP, terminal protein; TP-DNA, viral TP-DNA template; DBP, double-stranded DNA-binding protein; beta -ME, beta -mercaptoethanol; DTT, dithiothreitol; BS3, bis(sulfosuccinimidyl)suberate; BSA, bovine serum albumin; wt, wild-type.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Kornberg, A., and Baker, T. A. (1992) DNA Replication , 2nd Ed. , Freeman and Co., New York
2. Lohman, T. M., and Ferrari, M. E. (1994) Annu. Rev. Biochem. 63, 527-570[Medline] [Order article via Infotrieve]
3. Wold, M. (1997) Annu. Rev. Biochem. 66, 61-92[CrossRef][Medline] [Order article via Infotrieve]
4. Chase, J. W., and Williams, K. R. (1986) Annu. Rev. Biochem. 55, 103-136[CrossRef][Medline] [Order article via Infotrieve]
5. Revzin, A. (ed) (1990) The Biology of Nonspecific DNA-Protein Interactions , CRC Press, Boca Raton, FL
6. Kelly, T. J., Simancek, P., and Brush, G. S. (1999) Proc. Natl. Acad. Sci. U. S. A. 95, 14634-14639
7. Folmer, R. H. A., Folkers, P. J. M., Kaan, A., Jonker, A. J., Aelen, J. M. A., Konings, R. N. H., and Hilbers, C. W. (1994) Eur. J. Biochem. 224, 663-676[Medline] [Order article via Infotrieve]
8. Meyer, R. R., and Laine, P. S. (1990) Microbiol. Rev. 54, 342-380[Abstract/Free Full Text]
9. Curth, U., Urbanke, C., Greipel, J., Gerberding, H., Tiranti, V., and Zeviani, M. (1994) Eur. J. Biochem. 221, 435-443[Medline] [Order article via Infotrieve]
10. Salas, M. (1991) Annu. Rev. Biochem. 60, 39-71[CrossRef][Medline] [Order article via Infotrieve]
11. Salas, M., Miller, J. T., Leis, J., and DePamphilis, M. L. (1996) in DNA Replication in Eukaryotic Cells (DePamphilis, M. L., ed) , pp. 131-176, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
12. Salas, M. (1999) Genetic Engineering , Vol. 21 , Kluwer Academic/Plenum Publishers, New York
13. Méndez, J., Blanco, L., Esteban, J. A., Bernard, A., and Salas, M. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9579-9583[Abstract/Free Full Text]
14. Yoshikawa, H., Elder, J. H., and Ito, J. (1986) J. Gen. Appl. Microbiol. 32, 39-49
15. Pecenková, T., and Paces, V. (1999) J. Mol. Evol. 48, 197-208[Medline] [Order article via Infotrieve]
16. Martín, G., Lázaro, J. M., Méndez, E., and Salas, M. (1989) Nucleic Acids Res. 17, 3663-3672[Abstract/Free Full Text]
17. Gutiérrez, C., Martín, G., Sogo, J. M., and Salas, M. (1991) J. Biol. Chem. 266, 2104-2111[Abstract/Free Full Text]
18. Soengas, M. S., Gutiérrez, C., and Salas, M. (1995) J. Mol. Biol. 253, 517-529[CrossRef][Medline] [Order article via Infotrieve]
19. Soengas, M. S., Esteban, J. A., Salas, M., and Gutiérrez, C. (1994) J. Mol. Biol. 239, 213-226[CrossRef][Medline] [Order article via Infotrieve]
20. Gascón, I., Gutiérrez, C., and Salas, M. (2000) J. Mol. Biol. 296, 989-999[CrossRef][Medline] [Order article via Infotrieve]
21. Gascón, I., Lázaro, J. M., and Salas, M. (2000) Nucleic Acids Res. 28, 2034-2042[Abstract/Free Full Text]
22. Peñalva, M. A., and Salas, M. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 5522-5526[Abstract/Free Full Text]
23. Lázaro, J. M., Blanco, L., and Salas, M. (1995) Methods Enzymol. 262, 42-49[Medline] [Order article via Infotrieve]
24. Zaballos, A., and Salas, M. (1989) Nucleic Acids Res. 17, 10353-10366[Abstract/Free Full Text]
25. Pastrana, R., Lázaro, J. M., Blanco, L., García, J. A., Méndez, E., and Salas, M. (1985) Nucleic Acids Res. 13, 3083-3100[Abstract/Free Full Text]
26. Arwert, F., and Venema, G. (1974) J. Virol. 13, 584-589[Abstract/Free Full Text]
27. Yanish-Perron, C., Viera, J., and Messing, J. (1985) Gene (Amst.) 33, 103-199[CrossRef][Medline] [Order article via Infotrieve]
28. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
29. McDonell, M. W., Simon, M. N., and Studier, F. W. (1977) J. Mol. Biol. 110, 119-146[CrossRef][Medline] [Order article via Infotrieve]
30. Carthew, R. W., Chodosh, L. A., and Sharp, P. (1985) Cell 43, 438-448
31. Blanco, L., Lázaro, J. M., de Vega, M., Bonnín, A., and Salas, M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 12198-12202[Abstract/Free Full Text]
32. Beernink, H. T. H., and Morrical, S. W. (1998) Biochemistry 37, 5673-5681[CrossRef][Medline] [Order article via Infotrieve]
33. Masui, R., Mikawa, T., Kato, R., and Kuramitsu, S. (1998) Biochemistry 37, 14788-14797[CrossRef][Medline] [Order article via Infotrieve]
34. Kowalczykowski, S. C., and Eggleston, A. K. (1994) Annu. Rev. Biochem. 63, 991-1043[Medline] [Order article via Infotrieve]
35. Story, R. M., Weber, I. T., and Steitz, T. A. (1992) Nature 355, 318-324[CrossRef][Medline] [Order article via Infotrieve]
36. O'Donnell, M. E., Elias, P., Funnell, B. E., and Lehman, I. R. (1987) J. Biol. Chem. 262, 4260-4266[Abstract/Free Full Text]
37. Mapelli, M., Muhleisen, M., Persico, G., van der Zandt, H., and Tucker, P. A. (2000) J. Virol. 74, 8812-8822[Abstract/Free Full Text]
38. Boehmer, P. E., and Lehman, I. R. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8444-8448[Abstract/Free Full Text]
39. Boehmer, P. E., Craigie, M. C., Stow, N. D., and Lehman, I. R. (1994) J. Biol. Chem. 269, 29329-29334[Abstract/Free Full Text]
40. Gustafsson, C. M., Falkenberg, M., Simonsson, S., Valadi, H., and Elias, P. (1995) J. Biol. Chem. 270, 19028-19034[Abstract/Free Full Text]
41. Littler, E., Purifoy, D., Minson, A., and Powell, K. L. (1983) J. Gen. Virol. 64, 983-995[Abstract/Free Full Text]
42. Vaughan, P. J., Banks, L. M., Purifoy, D. J., and Powell, K. L. (1984) J. Gen. Virol. 65, 2033-2041[Abstract/Free Full Text]
43. Chiou, H. C., Weller, S. K., and Coen, D. M. (1985) Virology 145, 213-226[CrossRef][Medline] [Order article via Infotrieve]
44. Le Gac, N. T., Villani, G., Hoffmann, J. S., and Boehmer, P. E. (1996) J. Biol. Chem. 271, 21645-21651[Abstract/Free Full Text]
45. Falkenberg, M., Bushnell, D. A., Elias, P., and Lehman, I. R. (1997) J. Biol. Chem. 272, 22766-22770[Abstract/Free Full Text]
46. Tucker, P. A., Tsernoglou, D., Tucker, A. D., Coenjaerts, F. E. J., Leenders, H., and van der Vliet, P. (1994) EMBO J. 13, 2994-3002[Medline] [Order article via Infotrieve]
47. Dekker, J., Kanellopoulos, P. N., Loonstra, A. K., van Oosterhout, J. A., Leonard, K., Tucker, P. A., and van der Vliet, P. C. (1997) EMBO J. 16, 1455-1463[CrossRef][Medline] [Order article via Infotrieve]
48. Cleat, P. H., and Hay, R. T. (1989) EMBO J. 8, 1841-1848[Medline] [Order article via Infotrieve]
49. Stuiver, M. H., and Van der Vliet, P. C. (1990) J. Virol. 64, 379-386[Abstract/Free Full Text]
50. Mul, Y. M., and Van der Vliet, P. C. (1993) Nucleic Acids Res. 21, 641-647[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/25/22534    most recent
M202430200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map